Medial EarlySign

Medial EarlySign
Develops AI-powered decision support tools for personalized medical data interpretation and prediction.
About
What does Medial EarlySign do?
EarlySign develops machine learning-based decision support tools that analyze standard medical data to uncover hidden insights. These insights enable personalized interpretation of medical data, yielding individualized predictions and treatment options for each patient.
What is Medial EarlySign's revenue?
StartupHub estimates Medial EarlySign's annual revenue at $1.4M (range $813K to $2.7M, 66% confidence), based on comparable companies in the sector.
What is Medial EarlySign's valuation?
StartupHub estimates Medial EarlySign's effective valuation at $199.0M (range $125.0M to $300.0M, 10% confidence), based on comparable companies in the sector.
How much funding has Medial EarlySign raised?
Medial EarlySign has raised a total of $50M in funding. The most recent round on record is Series B.
Where is Medial EarlySign headquartered?
Medial EarlySign is headquartered in Tel Aviv, Israel.
When was Medial EarlySign founded?
Medial EarlySign was founded in 2009.
What industry does Medial EarlySign operate in?
Medial EarlySign operates in Healthcare, Decision Support, Insights, Detection, Prevention, HealthTech.
How many employees does Medial EarlySign have?
Medial EarlySign has approximately 8 people on record.
What is Medial EarlySign's current status?
Medial EarlySign's current operating status is: Inactive.
No comments yet. Be the first to share your take.